Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 216.29 billion as of January 9, 2026. Its market cap has decreased by -12.87% in one year.

Market Cap

216.29B

Enterprise Value

669.87B

Revenue

126.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

701.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 216.29B, an increase of 1,005.79%. That is a compound annual growth rate of 8.31%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	216.29B	0.57%
Dec 30, 2025	215.06B	-2.20%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
LG Energy Solution	84.94T
HD Hyundai Heavy Industries	63.92T
Hanwha Aerospace	62.46T
Doosan Enerbility	53.93T
Samsung C&T	43.77T
Hanwha Ocean	41.18T
HD Korea Shipbuilding & Offshore Engineering	31.61T
HD Hyundai Electric	30.52T

Market Cap Rankings